IRON SUCROSE Manufacturer Supplier in PCD Pharma Franchise
BRAND NAME FOR IRON SUCROSE IN PCD PHARMA FRANCHISE – SUCROFEE INJECTION
COMPOSITION: IRON SUCROSE 100 mg/5ml
For rates and Schemes – Contact 8284010553
Introduction of IRON SUCROSE
Sucrofee Injection, meticulously manufactured by Matins Pharma, encompasses the therapeutic benefits of Iron Sucrose 100 MG/5ML, offering a potent solution for iron deficiency anemia. Matins Pharma, a leading supplier in PCD Pharma Franchise and Third-Party Manufacturing, upholds stringent quality standards to ensure efficacy and safety in pharmaceutical products. Sucrofee Injection stands as a dependable option for addressing iron deficiency and improving patient health and vitality.
Uses of IRON SUCROSE
Sucrofee Injection, containing Iron Sucrose 100 MG/5ML, serves as a vital tool in the management of iron deficiency anemia. Iron Sucrose is an intravenous iron supplement used to replenish iron stores in the body when oral iron supplementation is inadequate or not tolerated. Sucrofee Injection is indicated for the treatment of iron deficiency anemia in patients with chronic kidney disease undergoing hemodialysis or peritoneal dialysis. By restoring iron levels in the body, Sucrofee Injection helps alleviate symptoms such as fatigue, weakness, and shortness of breath, and improves quality of life.
Side Effects of IRON SUCROSE
While Sucrofee Injection is generally well-tolerated, it’s essential to be aware of potential side effects that may occur. Common side effects of Iron Sucrose 100 MG/5ML may include headache, nausea, vomiting, diarrhea, abdominal pain, and injection site reactions. In some cases, patients may experience hypersensitivity reactions such as rash, itching, or swelling. Serious adverse effects such as anaphylaxis or hypotension may occur rarely. Patients should be monitored closely for signs of adverse reactions during and after administration of Sucrofee Injection, and treatment should be discontinued if necessary.
Safety Advice of IRON SUCROSE
Ensuring patient safety is paramount when administering Sucrofee Injection. Healthcare professionals should conduct a thorough assessment of patient history, including allergies and previous adverse reactions to iron supplements. Sucrofee Injection should be used with caution in patients with a history of hypersensitivity reactions to parenteral iron products. Patients should be screened for iron deficiency anemia and undergo appropriate laboratory testing before initiating treatment with Sucrofee Injection. Healthcare providers should monitor vital signs and observe patients for signs of adverse reactions during administration.
Dosage of IRON SUCROSE
The dosage of Sucrofee Injection may vary depending on the severity of iron deficiency and the patient’s iron status. In general, the recommended dose for adult patients with iron deficiency anemia undergoing hemodialysis or peritoneal dialysis is 100 to 200 mg of elemental iron administered intravenously per dialysis session. The total cumulative dose of Sucrofee Injection should not exceed 1 gram of elemental iron per week. Dosage adjustments may be necessary based on hemoglobin levels, iron parameters, and response to therapy.
The onset of action of Sucrofee Injection varies depending on the severity of iron deficiency and the patient’s response to treatment. Patients may experience symptomatic improvement, including resolution of anemia-related symptoms such as fatigue and weakness, within several weeks of initiating therapy. However, it may take several months to achieve optimal iron stores and hemoglobin levels. Regular monitoring of iron parameters and hemoglobin levels is essential to assess treatment efficacy and guide further management. Compliance with the prescribed treatment regimen and follow-up with healthcare providers are crucial for achieving favorable outcomes in patients receiving Sucrofee Injection therapy.
MATINS PHARMA IS A LEADING MANUFACTURER / SUPPLIER OF IRON SUCROSE
Matins Pharma, a leading manufacturer and supplier in the pharmaceutical industry, offers high-quality IRON SUCROSE 100 mg/5ml under the brand name SUCROFEE INJECTION.
Matins Pharma is one of the fastest growing Manufacturers suppliers pan India.
WE AT MATINS PHARMA AIM FOR :
- 100% quality assurance with high efficacy and excellent results
- Improved delivery experience and shorter delivery times
- Best in class service levels through regular communication with our Supplier partners and sharing the same in a transparent manner
- Customer satisfaction and understanding the latent needs of the our business partners
- Enriching our product mix by each passing day so as to provide you everything under one roof
Why Matins Pharma is among the best PCD Pharma Franchise Company in India:
- 100 % Quality Assurance
- Direct Dealing with Company Owners
- Very High Efficacy, WHO/GMP/GLP Certified Products
- Wide Product Range
- Best in Class Packings with UV Drip Off Finish
- High Margin Products with genuine rates
- Same Day Dispatch with trusted delivery partners
- Fair and Transparent Dealing – 100 % Commitment to agreement
Address: D-1A, Ahluwalia Complex Vill. Fatehpur, Sector 20, Panchkula, 134117, Haryana
Contact Number: 82840 10553, 99155 69932, 94175 06219India
We at Matins Pharma provide wide range of quality products. We offer the following ranges in PCD Pharma Franchise:
